{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:53:49Z","timestamp":1778874829618,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While implicated in therapeutic resistance, malignant progenitor cell cycle kinetics have been difficult to quantify in real-time. We developed an efficient lentiviral bicistronic fluorescent, ubiquitination-based cell cycle indicator reporter (<jats:italic>Fucci2BL<\/jats:italic>) to image live single progenitors on a defined niche coupled with cell cycle gene expression analysis. We have identified key differences in cell cycle regulatory gene expression and transit times between normal and chronic myeloid leukemia progenitors that may inform cancer stem cell eradication strategies.<\/jats:p>","DOI":"10.1038\/srep23885","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T09:04:45Z","timestamp":1459760685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Tracking of Normal and Malignant Progenitor Cell Cycle Transit in a Defined Niche"],"prefix":"10.1038","volume":"6","author":[{"given":"Gabriel","family":"Pineda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel P.","family":"Delos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Lambert-Fliszar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennarina L.","family":"Riso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Lazzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asako","family":"Sakaue-Sawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Miyawaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catriona H. M.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"key":"BFsrep23885_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1073\/pnas.1213021110","volume":"110","author":"Q Jiang","year":"2013","unstructured":"Jiang, Q. et al. ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia. Proc Natl Acad Sci USA 110, 1041\u20131046 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep23885_CR2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.stem.2012.12.011","volume":"12","author":"DJ Goff","year":"2013","unstructured":"Goff, D. J. et al. A Pan-BCL2 inhibitor renders bone-marrow-resident human leukemia stem cells sensitive to tyrosine kinase inhibition. Cell Stem Cell 12, 316\u2013328 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFsrep23885_CR3","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1073\/pnas.0900189106","volume":"106","author":"AE Abrahamsson","year":"2009","unstructured":"Abrahamsson, A. E. et al. Glycogen synthase kinase 3beta missplicing contributes to leukemia stem cell generation. Proc Natl Acad Sci USA 106, 3925\u20133929 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep23885_CR4","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/leu.2015.132","volume":"29","author":"AM Ford","year":"2015","unstructured":"Ford, A. M. et al. Protracted dormancy of pre-leukaemic stem cells. Leukemia 29, 2202\u20132207 (2015).","journal-title":"Leukemia"},{"key":"BFsrep23885_CR5","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1182\/blood-2012-02-412890","volume":"121","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-beta-catenin signaling. Blood 121, 1824\u20131838 (2013).","journal-title":"Blood"},{"key":"BFsrep23885_CR6","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3109\/10428194.2012.745524","volume":"54","author":"RA Van Etten","year":"2013","unstructured":"Van Etten, R. A. et al. Advances in the biology and therapy of chronic myeloid leukemia: proceedings from the 6th Post-ASH International Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Workshop. Leuk Lymphoma 54, 1151\u20131158 (2013).","journal-title":"Leuk Lymphoma"},{"key":"BFsrep23885_CR7","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1158\/2159-8290.CD-15-0298","volume":"5","author":"GK Behbehani","year":"2015","unstructured":"Behbehani, G. K. et al. Mass cytometric functional profiling of acute myeloid leukemia defines cell cycle and immunophenotypic properties that correlate with known responses to therapy. Cancer Discov 5, 988; doi: 10.1158\/2159-8290.CD-15-0298 (2015).","journal-title":"Cancer Discov"},{"key":"BFsrep23885_CR8","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1182\/blood-2013-07-517219","volume":"124","author":"M Krevvata","year":"2014","unstructured":"Krevvata, M. et al. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood 124, 2834\u20132846 (2014).","journal-title":"Blood"},{"key":"BFsrep23885_CR9","doi-asserted-by":"crossref","first-page":"13241","DOI":"10.18632\/oncotarget.3676","volume":"6","author":"Q Xie","year":"2015","unstructured":"Xie, Q. et al. CDC20 maintains tumor initiating cells. Oncotarget 6, 13241\u201313254 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep23885_CR10","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood-2010-11-318022","volume":"118","author":"EM Payne","year":"2011","unstructured":"Payne, E. M. et al. Ddx18 is essential for cell-cycle progression in zebrafish hematopoietic cells and is mutated in human AML. Blood 118, 903\u2013915 (2011).","journal-title":"Blood"},{"key":"BFsrep23885_CR11","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature14131","volume":"520","author":"D Walter","year":"2015","unstructured":"Walter, D. et al. Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells. Nature 520, 549\u2013552 (2015).","journal-title":"Nature"},{"key":"BFsrep23885_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.cell.2007.12.033","volume":"132","author":"A Sakaue-Sawano","year":"2008","unstructured":"Sakaue-Sawano, A. et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132, 487\u2013498 (2008).","journal-title":"Cell"},{"key":"BFsrep23885_CR13","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.1038\/srep04012","volume":"4","author":"T Oki","year":"2014","unstructured":"Oki, T. et al. A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0-G1 transition. Sci Rep 4, 4012, doi: 10.1038\/srep04012 (2014).","journal-title":"Sci Rep"},{"key":"BFsrep23885_CR14","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.4161\/15384101.2015.945381","volume":"13","author":"RL Mort","year":"2014","unstructured":"Mort, R. L. et al. Fucci2a: a bicistronic cell cycle reporter that allows Cre mediated tissue specific expression in mice. Cell Cycle 13, 2681\u20132696 (2014).","journal-title":"Cell Cycle"},{"key":"BFsrep23885_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2014.12.074","volume":"457","author":"M Yo","year":"2015","unstructured":"Yo, M., Sakaue-Sawano, A., Noda, S., Miyawaki, A. & Miyoshi, H. Fucci-guided purification of hematopoietic stem cells with high repopulating activity. Biochem Biophys Res Commun 457, 7\u201311 (2015).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep23885_CR16","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.1242\/dev.099226","volume":"140","author":"A Sakaue-Sawano","year":"2013","unstructured":"Sakaue-Sawano, A. et al. Visualizing developmentally programmed endoreplication in mammals using ubiquitin oscillators. Development 140, 4624\u20134632 (2013).","journal-title":"Development"},{"key":"BFsrep23885_CR17","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1182\/blood.V96.10.3392.h8003392_3392_3398","volume":"96","author":"P Salmon","year":"2000","unstructured":"Salmon, P. et al. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors. Blood 96, 3392\u20133398 (2000).","journal-title":"Blood"},{"key":"BFsrep23885_CR18","doi-asserted-by":"publisher","first-page":"e73801","DOI":"10.1371\/journal.pone.0073801","volume":"8","author":"M Tomura","year":"2013","unstructured":"Tomura, M. et al. Contrasting quiescent G0 phase with mitotic cell cycling in the mouse immune system. Plos One 8, e73801, doi: 10.1371\/journal.pone.0073801 (2013).","journal-title":"Plos One"},{"key":"BFsrep23885_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2121-12-2","volume":"12","author":"A Sakaue-Sawano","year":"2011","unstructured":"Sakaue-Sawano, A., Kobayashi, T., Ohtawa, K. & Miyawaki, A. Drug-induced cell cycle modulation leading to cell-cycle arrest, nuclear mis-segregation, or endoreplication. BMC Cell Biol 12, 2, doi: 10.1186\/1471-2121-12-2 (2011).","journal-title":"BMC Cell Biol"},{"key":"BFsrep23885_CR20","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1101\/gr.169508.113","volume":"24","author":"PJ Balwierz","year":"2014","unstructured":"Balwierz, P. J. et al. ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome Res 24, 869\u2013884 (2014).","journal-title":"Genome Res"},{"key":"BFsrep23885_CR21","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cell.2008.01.036","volume":"132","author":"DJ Rossi","year":"2008","unstructured":"Rossi, D. J., Jamieson, C. H. & Weissman, I. L. Stems cells and the pathways to aging and cancer. Cell 132, 681\u2013696 (2008).","journal-title":"Cell"},{"key":"BFsrep23885_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.stem.2010.05.016","volume":"7","author":"M Milyavsky","year":"2010","unstructured":"Milyavsky, M. et al. A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 7, 186\u2013197 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFsrep23885_CR23","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1084\/jem.20141438","volume":"212","author":"M Tesio","year":"2015","unstructured":"Tesio, M. et al. Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway. J Exp Med 212, 525\u2013538 (2015).","journal-title":"J Exp Med"},{"key":"BFsrep23885_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stem.2010.06.014","volume":"7","author":"M Mohrin","year":"2010","unstructured":"Mohrin, M. et al. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 7, 174\u2013185 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFsrep23885_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham, S. M. et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro . Blood 99, 319\u2013325 (2002).","journal-title":"Blood"},{"key":"BFsrep23885_CR26","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1002\/stem.1748","volume":"32","author":"F Pellicano","year":"2014","unstructured":"Pellicano, F. et al. The antiproliferative activity of kinase inhibitors in chronic myeloid leukemia cells is mediated by FOXO transcription factors. Stem Cells 32, 2324\u20132337 (2014).","journal-title":"Stem Cells"},{"key":"BFsrep23885_CR27","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2010-09-307256","volume":"118","author":"A Slupianek","year":"2011","unstructured":"Slupianek, A. et al. Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia. Blood 118, 1062\u20131068 (2011).","journal-title":"Blood"},{"key":"BFsrep23885_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/leu.2012.294","volume":"27","author":"A Slupianek","year":"2013","unstructured":"Slupianek, A. et al. BCR-ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability. Leukemia 27, 629\u2013634 (2013).","journal-title":"Leukemia"},{"key":"BFsrep23885_CR29","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti, D., Jamieson, C., Goldman, J. & Skorski, T. Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 120, 2254\u20132264 (2010).","journal-title":"J Clin Invest"},{"key":"BFsrep23885_CR30","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1038\/ncomms4347","volume":"5","author":"A Alvarez-Quilon","year":"2014","unstructured":"Alvarez-Quilon, A. et al. ATM specifically mediates repair of double-strand breaks with blocked DNA ends. Nat Commun 5, 3347, doi: 10.1038\/ncomms4347 (2014).","journal-title":"Nat Commun"},{"key":"BFsrep23885_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.dnarep.2005.10.005","volume":"5","author":"A Slupianek","year":"2006","unstructured":"Slupianek, A., Nowicki, M. O., Koptyra, M. & Skorski, T. BCR\/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells. DNA Repair (Amst) 5, 243\u2013250 (2006).","journal-title":"DNA Repair (Amst)"},{"key":"BFsrep23885_CR32","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/leu.2008.78","volume":"22","author":"M Koptyra","year":"2008","unstructured":"Koptyra, M., Cramer, K., Slupianek, A., Richardson, C. & Skorski, T. BCR\/ABL promotes accumulation of chromosomal aberrations induced by oxidative and genotoxic stress. Leukemia 22, 1969\u20131972 (2008).","journal-title":"Leukemia"},{"key":"BFsrep23885_CR33","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tcb.2012.10.011","volume":"23","author":"V D'Angiolella","year":"2013","unstructured":"D'Angiolella, V., Esencay, M. & Pagano, M. A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis. Trends Cell Biol 23, 135\u2013140 (2013).","journal-title":"Trends Cell Biol"},{"key":"BFsrep23885_CR34","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12967-015-0453-9","volume":"13","author":"A Sadarangani","year":"2015","unstructured":"Sadarangani, A. et al. GLI2 inhibition abrogates human leukemia stem cell dormancy. J Transl Med 13, 98, doi: 10.1186\/s12967-015-0453-9 (2015).","journal-title":"J Transl Med"},{"key":"BFsrep23885_CR35","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMoa040258","volume":"351","author":"CH Jamieson","year":"2004","unstructured":"Jamieson, C. H. et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351, 657\u2013667 (2004).","journal-title":"N Engl J Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep23885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep23885","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep23885.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:48:02Z","timestamp":1672890482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep23885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,29]]}},"alternative-id":["BFsrep23885"],"URL":"https:\/\/doi.org\/10.1038\/srep23885","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]},"assertion":[{"value":"22 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23885"}}